Cerebral Energy Metabolism After Subarachnoid Hemorrhage
Introduction
• Recent studies of oxidative metabolism have clarified the relationship between nutritional supply and cerebral energy requirements after ischemic and anoxic insults. 1 Disturbances of cerebral energy metabolism also may be responsible for the clinical sequelae of subarachnoid hemorrhage (SAH), yet, at present there is little available information in this regard. Cerebral blood flow is normally under the influence of cerebral metabolic requirements, but after SAH, spasm may render the microcirculation insensitive to alterations of cerebral energy needs.
The purpose of this study was to determine the effects of SAH on brain energy metabolism. A series of experiments was performed using the rhesus monkey, during which the average cerebral metabolic consumption of glucose and oxygen were measured in relationship to other parameters of developing ischemia. It became apparent that the presence of intracranial hypertension significantly modified the sequence of hemodynamic events. Thereafter, a regional metabolic analysis was performed in the rat, with normal intracranial pressure (ICP), to characterize the disturbances of regional energy metabolism induced by the presence of arterial blood in the subarachnoid space.
FEIN
catheter passed transfemorally and connected to a P-23-Db Statham transducer. Cisternal pressure was monitored and controlled by a double lumen scalp vein needle, one arm of which was connected to a P23V Statham transducer. Plasma glucose levels were maintained between 120 and 152 mg % by 5% dextrose and saline solution administered by intravenous infusion at a rate of 2 to 3 cc per kilogram per hour. Hydrogen gas then was administered by inhalation until saturation of the brain was achieved. 2 Its exponential washout then was detected polarographically by a single platinized-platinum electrode placed in the distal end of the sagittal sinus. Average total cerebral blood flow was obtained by resolving the biexponential decay into its initial weights and half times. 3 A-VO 2 content, 4 A-V glucose, 6 cerebrospinal fluid (CSF) glucose, CSF pH and CSF lactate/pyruvate ratios were determined. 6 Lactate concentrations in CSF and serum were estimated spectrofiuorometrically according to Bergmeyer.' CSF pyruvate was determined according to the method of Lowry et al. 1 After control studies, the animals were divided into three groups:
1. Six animals underwent isobaric injection (ICP 5 to 7 mm Hg) of 0.50 cc of fresh isologous arterial blood into the cisterna magna (isobaric cisternal).
2. Six animals underwent bilateral trephination and unilateral isobaric injection of 0.50 cc of isologous arterial blood into the subarachnoid space over the right or left cerebral convexity (isobaric convexity).
3. Seven animals underwent the hyperbaric (ICP 20 to 24 mm Hg) injection of 0.50 cc of isologous arterial blood into the cisterna magna (hyperbaric cisternal). Serial blood flow and metabolic consumption studies were then performed up to 12 hours after induced SAH in all three groups.
A regional analysis of energy metabolism then was carried out using Sprague-Dawley rats weighing 200 to 300 gm. After brief ether induction, a tracheostomy was performed and arterial blood gases were controlled with closed ventilation using an anesthetic mixture of nitrous oxide/oxygen and curare. Arterial pH was maintained between 7.377 and 7.415, arterial Po, varied between 100 and 140 mm Hg, and arterial Pco, was maintained between 34 and 42 mm Hg. Aortic blood pressure and cisternal pressure were monitored as previously described. Plasma glucose levels were maintained between 125 and 144 mg % by a 5% dextrose and saline solution administered intravenously at a rate of 1 cc per kilogram per hour. Fresh homologous cardiac blood (0.25 cc), taken from a donor rat, was slowly injected into the cisterna magna. In 47 rats, cisternal pressure was maintained between 3 and 6 mm Hg after SAH by withdrawing 0.5 to 1.8 cc of bloody CSF. At selected intervals, both before (n = 5) and after (n = 19) induced SAH, substrate metabolism was interrupted by decapitation into liquid nitrogen. Representative chips of cerebrum, cerebellum, brain stem and basal ganglia were weighed and extracted in 3 M HC10 4 and neutralized with 2 M KHCO 3 . The supernatant was assayed for levels of tissue glucose, lactate, pyruvate, phosphocreatine (PCr), adenosine triphosphate (ATP), adenosine diphosphate (ADP) and adenosine monophosphate (AMP), according to methods described by Lowry et al. 1 The energy charge potential (ECP) which describes the ratio of high energy phosphates to the total adenine nucleotide pool was calculated according to Atkinson 8 as: ECP = ATP + 0.5 ADP ATP + ADP + AMP Seventeen rats, in whom SAH also was induced, were killed by decapitation. Representative specimens of cerebrum, cerebellum, basal ganglia and brain stem were removed over ice and homogenized in 10 volumes of 0.25 M sucrose. Six rats were similarly prepared but SAH was not induced. The distribution of soluble, bound and latent hexokinase in brain homogenates was determined in control and SAH animals by the spectrophotometric determination of Knull et al. 
Results

CEREBRAL METABOLIC CONSUMPTION OF SUBSTRATES
Mean values for three groups of monkeys did not differ significantly. Mean cerebral blood flow (40.6 cc/100 gm per minute), cerebral metabolic consumption rates for oxygen (3.7 cc/100 gm per minute), and glucose (5.9 cc/100 gm per minute), and lactate/pyruvate ratios (11.2) were obtained by pooling the means of all three groups. The changes in these values in subsequent measurements are expressed as percentage change from control measurements.
1. In the isobaric cisternal group ( fig. 1) , the metabolic consumption rates (CMR) of oxygen and glucose decreased over the first hour after hemorrhage. The depression in cerebral blood flow was delayed for approximately two and one-half hours after SAH. The CSF lactate/pyruvate ratios remained unchanged until the fourth hour, although the concentration of both substrates promptly increased after SAH. Eventually, ischemic changes indicated by a depressed cerebral blood flow rate ( fig. 2) , and progressively increasing CSF lactate/pyruvate ratios were noted ( fig. 3 ). 2. In the isobaric convexity group, CMR0 2 remained normal until ten hours ( fig. 4) , and CMR glucose was transiently elevated. CBF remained at normal levels for six hours after SAH. However, evidence of ischemia was present earlier with a mild but persistent elevation of CSF lactate immediately after SAH ( fig. 3 ). Lactale/pyruvate ratios in three groups of monkeys. 
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FIGURE 4
Cerebral blood flow and metabolism in the isobaric convexity group. There was no detectable increase in average CBF after focal deposition of blood until ten hours after SAH. An increase in glucose extraction after four hours may reflect the presence of a mild degree of ischemia.
trol levels because of a secondary rise in the A-VO 2 extraction rate. By four hours after SAH, the CMR0 2 had also fallen to 37% of control values. Glucose extraction and CMR glucose initially increased, but by three hours after SAH they had returned to normal and were consistently depressed thereafter. The inadequate perfusion, and resulting ischemia, was also evident in a rapid and sustained rise of CSF lactate/pyruvate ratio ( fig. 3 ).
REGIONAL ENERGY METABOLISM
Subarachnoid hemorrhage was induced in 56 rats. In nine rats an uncontrolled metabolic acidosis with systemic hypotension occurred, and the biochemical data were not tabulated. For clarity of illustration, only the mean values are given in figure 6 . In five control animals only the basal ganglia had a glucose concentration (1.24 mM/kg/ww) significantly lower (P < 0.01) than the other three regions (cerebrum, 1.49; cerebellum, 1.51; brain stem, 1.44 mM/kg/ww). After SAH, mean glucose levels in both cerebrum and basal ganglia increased to 120% to 130% of control for approximately three hours; however, the standard deviations and standard errors of the mean overlapped widely. Glucose levels in cerebrum dropped significantly between four and six hours after SAH. No significant changes in tissue glucose level were found in either cerebellum, basal ganglia or brain stem after SAH.
The hexokinase distribution in normal brain was in favor of the bound form in cerebrum (63.6%), cerebellum (58.2%), and basal ganglia (58%). In the brain stem the relative amount in the bound form was consistently between 40% and 50% with a mean value of 43.5%. After SAH significant solubilization of hexokinase activity was noted in the cerebrum and cerebellum (P < 0.01, < 0.01) lasting for three to four hours, after which an increased binding to mitochondria was present. By five hours 100% of the crude enzyme was bound to mitochondria in both regions. A slight solubilization of hexokinase activity was present in the basal ganglia for the first hours after SAH, following which binding returned to control values. An increased binding of hexokinase was noted in the first sample taken after SAH from the brain stem. Following this initial rise, the degree of binding was similar to control values for the remainder of the study ( fig. 6C) .
Mean lactate levels for individual regions in control animals were between 1.7 and 2.1 mM/kg/ww and pyruvate levels ranged between 8.2 and 11.7 mM/kg/ww. There were no significant changes in the lactate/pyruvate ratio of any of the regions examined for up to three hours after SAH (fig. 6B ). The absolute lactate levels increased slightly in samples from brain stem. However, these were accompanied by corresponding rises in pyruvate levels. At four hours after SAH, tissue lactate increased 43% in cerebrum, 56% in cerebellum and 58% in basal ganglia. These concentrations remained elevated through the period of observation, while pyruvate levels remained near control values. The overall lactate/pyruvate ratio increased (P < 0.001) from control values to 53 in cerebrum, 65 in cerebellum and 107 in basal ganglia. The rise in brain stem lactate/pyruvate ratio was of questionable significance (P < 0.1).
In control animals phosphocreatine concentration in cerebrum was 1.5 mM/kg/ww, cerebellum 1.63 mM/kg/ww (P < 0.1), brain stem 2.1 mM/kg/ww (P < 0.01) and basal ganglia 1.3 mM/kg/ww (P < 0.01). After SAH an initial decline of PCr to 40% of control values was noted in brain stem. This level was maintained until the fourth hour of SAH at which time a further drop was noted. After this period PCr was no longer detectable in brain stem. By contrast, PCr concentrations in cerebrum and cerebellum were unchanged through the second hour after SAH following which these levels progressively decreased ( fig. 6D ). There were no appreciable changes in phosphocreatine concentration throughout the period of observation within the basal ganglia.
Energy charge potential was calculated from the individual concentrations of adenine nucleotides and expressed in arbitrary units. Absolute levels of nucleotides varied in regional studies in the steady state condition, but the ratios of ATP, ADP and AMP remained approximately 110, 10, and 1. The energy charge potential for cerebrum was 0.951; for cerebellum, 0.933; for basal ganglia, 0.946; and for brain stem 0.961. There was no marked change in any of these values until four hours after SAH. At that time, the energy charge potential of cerebral sections progressively declined until levels of 0.690 were Phosphocreatine levels remained at control levels until four to six hours. These levels became imperceptible in brain stem after six hours, in cerebellum after eight hours, and in cerebrum after ten hours. E. Energy charge potential which reflects the relative levels of high energy phosphates was maintained until PCr levels were significantly depressed. The maintenance of both energy sources in basal ganglia is noted.
